Palbociclib has been shown to be effective in treating metastatic breast cancer when used in combination with endocrine therapies. This study evaluated the effects of palbociclib plus letrozole as ...
SAN ANTONIO — Extended adjuvant endocrine therapy with letrozole conferred no significant survival benefit to postmenopausal women with hormone receptor–positive breast cancer who completed 5 years of ...
The optimal duration of adjuvant therapy for postmenopausal women with estrogen receptor-positive (ER+) early-stage breast cancer is unknown. Adjuvant therapy with aromatase inhibitors (AIs) after 5 ...
SAN ANTONIO — Extended adjuvant endocrine therapy with letrozole improved DFS compared with placebo among postmenopausal women with hormone receptor-positive breast cancer who completed previous ...
Double-Hit Gene Expression Signature Defines a Distinct Subgroup of Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma Postmenopausal women with ER-positive primary BC and tumors greater than ...
In the middle of this year's Breast Cancer Awareness Month, women with breast cancer have heard some encouraging news about treatment. A hormonal therapy called letrozole, also known as Femara, may ...
Detection of Relapse by Tumor Markers Versus Imaging in Children and Adolescents With Nongerminomatous Malignant Germ Cell Tumors: A Report From the Children’s Oncology Group Premenopausal women with ...
Pfizer announced that the Food and Drug Administration (FDA) has accepted for filing and granted Priority Review to the New Drug Application (NDA) for palbociclib in combination with letrozole, as a ...
Treatment with the aromatase inhibitor letrozole (Femara) can reduce the risk of breast cancer recurrence even when initiated one to seven years after a course of tamoxifen therapy. The results of a ...
Adjuvant therapy with tamoxifen is associated with improved survival rates in postmenopausal women with early-stage breast cancer. This treatment is, however, associated with considerable toxicity and ...
In the middle of this year's Breast Cancer Awareness Month, women with breast cancer have heard some encouraging news about treatment. A hormonal therapy called letrozole, also known as Femara, may ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback